The credit line has been increased twice over the past 9 months or so.....effectively raising it 3.5 times the $2m it stood at 9 months ago. Further, the credit line was initiated, if I recall correctly when all this growth started back in early 2014. From zilch to $7M on a company with a total worth of just over $16M presently. That's pretty dang bullish, IMO.
I had not noticed it yet. This is HUGE, IMO. From 4M to 7M and the time extension....big confidence in IFON shown by lender.
Over half my shares are lent as of today (shorted). I think, for once, I'm glad and see any shorting here as rocket fuel.
I mean, I think the quarter will be excellent....but if not exceptional, the continuing outlook has to be, given this news.
Thanks for the note. It has been a long time but I recall you as jacknjill, not by your prior board name.
I hope you are doing really well. Actually, I'm not sure what board we met on, perhaps DXPE?? It wasn't ELON. I'm not familiar with that company. I've never fooled with bios much but when neebhome mentioned AVXL very recently it was about .65 with very recent progress news on its drug for one of the most widespread problems out there, Alzheimer's.....and there are no highly effective drugs on the market. So, it was rather a no-brainer, IMO. I sold most yesterday, even some at 1.58 yesterday, and kept some shares that are paid for from profits taken to see what develops there. What an incredible move and I surely thank neebhome for her mention of AVXL at the IFON board.
I'm actually planning on scaling down my involvement with stocks; I've been "intending" for years but plan to carry it out this year. God has really blessed me. So, I'm not moving toward new investments right now.
IFON will report in the morning and I think it could possible be a great report. If it is, I think that stock will reach a point this year where I'll largely exit it at a much higher price. We'll see.
I hope IDRA works out great for you.....hope it pulls an AVXL move soon. A8bil is in IFON and posts there every so often.
God's blessings on you and your family,
Absolutely I remember you and glad you do me, pal.
ABHI would not be my type now, actually, but not because of lack of outlook but lack of financial stability.
However, well over a year ago, it was my value type, even though a penny stock. Before it transitioned to this business, its medical device business was profitable, generally speaking. The balance sheet was very, very healthy for a penny stock. I knew nothing about the company's intent to abandon that and merge with Veloxum, but stuck with it when it did because the potential sounded very good. I sure didn't know the cash burn would be as big and didn't expect the delays.
But here we are and on the same page about the potential and the concerns. Hopefully, it's going to pay off.
The market realizes it (but thanks for the news) and clearly it disagrees with your valuation notions relative the progress report of the Alzheimer's candidate at Anavex.
I agree golf.....it's not tested sufficiently yet; but I do think we've got at least one more good day in this before a rest. When it planted its feet last Friday, we brought in a new crowd here, IMO. The volume today was compelling. It may rest here, but I'm thinking we may head pretty much straight to 2 bucks before that rest comes. We'll see.
Fidelity shows a close of 1.46. It doesn't change the validity of your post, which I find a great understatement.....unbelievable strength and a close just above a key price of 1.45 that some state as a resistance point; that means it is now support....next stop, $2.10?
These numbers are small but it was zero last quarter. This surely is not a time I'm going to consider selling....maybe if it was .20, I would de-risk some given the same exact situation and knowledge as right now, but it's already being priced for bankruptcy concern. So, with some prospects showing life, I'm not taking a bankruptcy driven price at this juncture.
IMO, this is the deal; if the company can multiply its revenue quarter over quarter for a spell, there would be little question about us being much, much higher in stock price in a year......and I don't doubt at all that it can do it. They forecast doubling in the1st quarter (i.e. $374,000). By my evaluation, if they doubled once more in the 2nd quarter to near $750K, the company would be very close to breakeven.
Here's the rub and why doubt exists; they've got to find some financing to get where they want to go. It's a gamble, pure and simple, as a stockholder....but if they persuade some people to invest (lend, etc.).... well, this $187,920 in sales for the first quarter of the product (as you point out...it's only the consumer version and the sales actually only include a part of the quarter) being on the market.......Well, given the right context being that it literally just went on sale, it doesn't look bad to me, IMO.
The financing issue is what's holding the stock price in check, IMO.
IMO, it will. I've been focused on that starting inventory balance for the quarter about to be reported ever since the last report came out. Given the favorable remarks in the earnings press release.....and the CEO interviews mentioned on this board.......I've got to go with good inventory turns occurring. If so, IMO, IFON will light it up when the report comes.....IMO,
It will have to pause and sometime but it may be 2 to 3 bucks by then. The company has science behind the run. Your name i flip for profit works sometimes....that is, trying to make a quick return......but clearly, this one is not working for you; the ones who have made big money are the ones who were loading up on the news about the trial results when it was available for well half the current price. Flipping would not have got you to that point. Your name implies you'll never have such an experience. Personally, I sold enough shares today to more than cover my cost and now am riding a good position of free shares to have the opportunity to realize the real potential that is clearly here.
Thank you so much for mentioning AVXL. I ended up accumulating a good position at an average cost of .78. I've sold 2/3, getting as high as 1.58 in this big run today.....so I've way more than covered my cost of my remaining 1/3. The potential for the drug for AD is mind-boggling but it's early in trials. Anyway, dibs go to you, my friend. Thanks!!!
Well, I just added in the 9 teens on this dip, because that's what I think this is. I don't believe B&B will cause this to keep from advancing to 11 and better soon. JMO. This dip is on miniscule volume, btw.
Your post does not warrant a response. I just wanted to add that a dump will take place because on strong momentum stocks, there always comes a time for a dump, even if short-lived. The problem is, you are assuming a dump from the 1.13 level.....change your assumption to a dump from the 3 to 5 dollar level, maybe back to the 2s for a rest....and you might be right.